Editorial: Insights on neuroinflammatory response by microglia-targeted pharmacology
Jacob Raber, Hector J. Caruncho, Philippe De Deurwaerdere, Massimo Grilli
Front. Pharmacol.. 2023-05-04; 14:
DOI: 10.3389/fphar.2023.1205859
Lire sur PubMed
Front. Pharmacol.. 2023-05-04; 14:
DOI: 10.3389/fphar.2023.1205859
Lire sur PubMed
Raber J(1), Caruncho HJ(2), De Deurwaerdere P(3), Grilli M(4).
Author information:
(1)Behavioral Neuroscience, Oregon Health and Science University, Portland, OR,
United States.
(2)University of Victoria, Victoria, BC, Canada.
(3)Université de Bordeaux, CNRS UMR5287, Bordeaux, France.
(4)Department of Pharmacy, University of Genova, Genova, Italy.
Comment on
Editorial on the Research Topic Insights on neuroinflammatory response by
microglia-targeted pharmacology.
DOI: 10.3389/fphar.2023.1205859
PMCID: PMC10192893
PMID: 37214437
Conflict of interest statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.